List of Studies ( Metabolite:HexCer 20:2;O2/22:0)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003751 | AN006158 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Blood | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003751 | AN006158 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Urine | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003751 | AN006159 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Blood | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003751 | AN006159 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Urine | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003130 | AN005134 | Pulmonary maternal immune activation does not extend through the placenta but leads to fetal metabolic adaptation - Maternal blood | Blood | Mouse | University of Copenhagen | LC-MS | |
| ST003103 | AN005077 | Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients using a Multiplatform Mass Spectrometry-based Metabolomics Approach | Blood | Human | COVID-19 | Universidad CEU San Pablo | GC-MS/LC-MS |
| ST003103 | AN005078 | Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients using a Multiplatform Mass Spectrometry-based Metabolomics Approach | Blood | Human | COVID-19 | Universidad CEU San Pablo | GC-MS/LC-MS |
